New Blood Test ‘Clock’ Can Predict Alzheimer’s Symptoms Years in Advance
- Feb 19
- 2 min read
A simple blood test may soon tell doctors not only if a patient is at risk for Alzheimer’s disease but exactly when they will likely begin to suffer from memory loss and confusion.
In a study published in Nature Medicine, researchers from Washington University School of Medicine in St. Louis revealed a new statistical model that acts as a "clock" for the disease. By analyzing specific protein levels in the blood, the model can predict the onset of Alzheimer's symptoms within a margin of error of three to four years.
The test focuses on a protein called p-tau217, which accumulates in the brain as the disease progresses. According to lead author Kellen K. Petersen, these protein levels build up in a consistent pattern, similar to the rings of a tree. "If we know how many rings a tree has, we know how many years old it is," Petersen explained. "The age they become positive strongly predicts when someone is going to develop Alzheimer's symptoms".
The study analyzed data from over 600 older adults who were cognitively healthy at the start of the research. The findings suggest that age plays a critical role in the speed of the disease: older individuals who test positive for elevated protein levels tend to develop symptoms much faster than younger individuals. For instance, a person with elevated p-tau217 at age 80 might develop symptoms in 11 years, whereas a 60-year-old might not show symptoms for 20 years.
Currently, diagnosing Alzheimer's requires expensive brain imaging or invasive spinal fluid tests. A blood test offers a cheaper, more accessible alternative. While experts caution that the test is not yet ready for widespread use in doctor's offices for healthy people, its immediate impact will be on research.
"These clock models could make clinical trials more efficient by identifying individuals who are likely to develop symptoms within a certain period of time," said Petersen. This ensures that experimental preventative treatments are tested on the patients most likely to benefit from them.
Despite the excitement, the medical community urges caution regarding individual diagnosis. Experts note that a three-to-four-year window of uncertainty is still a significant margin for patients making life decisions, such as retirement planning. Furthermore, other health factors like kidney disease can influence protein levels, requiring further validation of the test across diverse populations.
"In the near term, these models will accelerate our research," said senior author Dr. Suzanne Schindler. "Eventually, the goal is to be able to tell individual patients when they are likely to develop symptoms".
🔖 Sources
Keywords: Predict Alzheimer’s symptoms
Predict Alzheimer’s symptoms
Comments